Imd Companies
iMD Companies, Inc. is a holding company which, through its subsidiaries, manufactures, markets, and distributes equipment for the hydroponics industry. It also develops and manufactures environmental controllers. iMD Companies, Inc. was formerly known as R-Quest Hydroponics, Inc. and changed its name to iMD Companies, Inc. in January 2014. iMD Companies, Inc. was founded in 1993 and is based in … Read more
Imd Companies (ICBU) - Net Assets
Latest net assets as of June 2025: $-1.97 Million USD
Based on the latest financial reports, Imd Companies (ICBU) has net assets worth $-1.97 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($376.29K) and total liabilities ($2.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.97 Million |
| % of Total Assets | -524.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | -148.99% |
| 10-Year Change | N/A |
| Growth Volatility | 56.92 |
Imd Companies - Net Assets Trend (2013–2024)
This chart illustrates how Imd Companies's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Imd Companies (2013–2024)
The table below shows the annual net assets of Imd Companies from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.63 Million | -76.91% |
| 2023-12-31 | $-1.48 Million | -10.47% |
| 2022-12-31 | $-1.34 Million | -28.10% |
| 2021-12-31 | $-1.05 Million | -119.57% |
| 2020-12-31 | $5.36 Million | +0.31% |
| 2019-12-31 | $5.34 Million | -0.74% |
| 2018-12-31 | $5.38 Million | -57.14% |
| 2017-12-31 | $12.56 Million | -13.56% |
| 2016-12-31 | $14.53 Million | +1398.63% |
| 2015-12-31 | $-1.12 Million | -114.14% |
| 2014-12-31 | $-522.36K | -141.85% |
| 2013-12-31 | $1.25 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Imd Companies's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 419098500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.43 Million | % |
| Total Equity | $-2.74 Million | 100.00% |
Imd Companies Competitors by Market Cap
The table below lists competitors of Imd Companies ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imd Companies's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,484,078 to -2,743,154, a change of -1,259,076.
- Net loss of 1,252,658 reduced equity.
- Other comprehensive income increased equity by 4,016,070.
- Other factors decreased equity by 4,022,488.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.25 Million | -45.66% |
| Other Comprehensive Income | $4.02 Million | +146.4% |
| Other Changes | $-4.02 Million | -146.64% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Imd Companies's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.01 | $0.00 | x |
| 2017-12-31 | $0.01 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imd Companies utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -123.00%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-11.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -134.77% | -479.82% | 0.13x | 2.16x | $-1.81 Million |
| 2014 | 0.00% | -559.04% | 0.29x | 0.00x | $-882.87K |
| 2015 | 0.00% | -84726.63% | 0.00x | 0.00x | $-718.17K |
| 2016 | 4.13% | 3.59% | 0.32x | 3.62x | $-416.43K |
| 2017 | -0.23% | -0.10% | 0.79x | 3.08x | $-783.14K |
| 2018 | -8.64% | -25.25% | 0.29x | 1.17x | $-1.00 Million |
| 2019 | -0.74% | 0.00% | 0.00x | 1.18x | $-573.99K |
| 2020 | -1.35% | 0.00% | 0.00x | 1.18x | $-608.53K |
| 2021 | 0.00% | -548.81% | 0.06x | 0.00x | $-52.36K |
| 2022 | 0.00% | -3757.55% | 0.04x | 0.00x | $-180.35K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-52.23K |
| 2024 | 0.00% | -123.00% | 0.94x | 0.00x | $-978.34K |
Industry Comparison
This section compares Imd Companies's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imd Companies (ICBU) | $-1.97 Million | -134.77% | N/A | $7.74 |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |